Hugh Fan
Deep value, small-cap, foreign companies, CFA

Baxano Surgical: A $3 Dollar Stock Trading At $1.

Baxano Surgical (NASDAQ:BAXS) is a medical device company focused on minimum invasive surgery (MIS) equipments, which have shown superior clinical results comparing to traditional open surgeries. I rate BAXS as a strong buy for the following reasons:

  1. BAXS's revenue and earnings have bottomed in 2013 and will grow explosively in 2014
  2. Insider buys and positive technical signals support the stock price
  3. Legal overhangs are gone and BAXS has no POD exposures
  4. BAXS has a healthy balance sheet with enough cash to operate for the remaining of 2014

Company Description and Investment Reasons

BAXS was formed in 2013 when TranS1 acquired privately held Baxano Inc. and adopted the Baxano Surgical Inc. name. The deal establishes BAXS as a unique,

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details